Lu­mi­cell nabs FDA ap­proval for drug-de­vice breast can­cer de­tec­tion sys­tem

The Mass­a­chu­setts-based biotech Lu­mi­cell won FDA ap­proval on Thurs­day for its drug-de­vice com­bi­na­tion prod­uct used to help de­tect resid­ual can­cer in breast can­cer pa­tients, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.